Erica S Shenoy1, Hang Lee2, Jessica A Cotter3, Winston Ware4, Douglas Kelbaugh5, Eric Weil6, Rochelle P Walensky7, David C Hooper8. 1. Harvard Medical School, Boston, MA; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA; Infection Control Unit, Massachusetts General Hospital, Boston, MA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA. Electronic address: eshenoy@partners.org. 2. Department of Biostatistics, Massachusetts General Hospital, Boston, MA. 3. Infection Control Unit, Massachusetts General Hospital, Boston, MA. 4. Clinical Care Management Unit, Massachusetts General Hospital, Boston, MA. 5. Partners Information Systems, Massachusetts General Hospital and Massachusetts General Physicians Organization, Boston, MA. 6. Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA; Massachusetts General Physicians Organization. 7. Harvard Medical School, Boston, MA; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA. 8. Harvard Medical School, Boston, MA; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA; Infection Control Unit, Massachusetts General Hospital, Boston, MA. Electronic address: dhooper@mgh.harvard.edu.
Abstract
BACKGROUND: A history of methicillin-resistant Staphylococcus aureus (MRSA) is a determinant of inpatient bed assignment. METHODS: We assessed outcomes associated with rapid testing and discontinuation of MRSA contact precautions (CP) in a prospective cohort study of polymerase chain reaction (PCR)-based screening in the Emergency Department (ED) of Massachusetts General Hospital. Eligible patients had a history of MRSA and were assessed and enrolled if documented off antibiotics with activity against MRSA and screened for nasal colonization (subject visit). PCR-negative subjects had CP discontinued; the primary outcome was CP discontinuation. We identified semiprivate rooms in which a bed was vacant owing to the CP status of the study subject, calculated the hours of vacancy, and compared idle bed-hours by PCR results. Program costs were compared with predicted revenue. RESULTS: There were 2864 eligible patients, and 648 (22.6%) subject visits were enrolled. Of these, 65.1% (422/648) were PCR-negative and had CP discontinued. PCR-negative subjects had fewer idle bed-hours compared with PCR-positive subjects (28.6 ± 25.2 vs 75.3 ± 70.5; P < .001). The expected revenues from occupied idle beds and averted CP costs ranged from $214,160 to $268,340, and exceeded the program costs. CONCLUSION: A program of targeted PCR-based screening for clearance of MRSA colonization resulted in expected revenues and decreased CP costs that outweighed programmatic costs.
BACKGROUND: A history of methicillin-resistant Staphylococcus aureus (MRSA) is a determinant of inpatient bed assignment. METHODS: We assessed outcomes associated with rapid testing and discontinuation of MRSA contact precautions (CP) in a prospective cohort study of polymerase chain reaction (PCR)-based screening in the Emergency Department (ED) of Massachusetts General Hospital. Eligible patients had a history of MRSA and were assessed and enrolled if documented off antibiotics with activity against MRSA and screened for nasal colonization (subject visit). PCR-negative subjects had CP discontinued; the primary outcome was CP discontinuation. We identified semiprivate rooms in which a bed was vacant owing to the CP status of the study subject, calculated the hours of vacancy, and compared idle bed-hours by PCR results. Program costs were compared with predicted revenue. RESULTS: There were 2864 eligible patients, and 648 (22.6%) subject visits were enrolled. Of these, 65.1% (422/648) were PCR-negative and had CP discontinued. PCR-negative subjects had fewer idle bed-hours compared with PCR-positive subjects (28.6 ± 25.2 vs 75.3 ± 70.5; P < .001). The expected revenues from occupied idle beds and averted CP costs ranged from $214,160 to $268,340, and exceeded the program costs. CONCLUSION: A program of targeted PCR-based screening for clearance of MRSA colonization resulted in expected revenues and decreased CP costs that outweighed programmatic costs.
Authors: Menno R Vriens; Hetty E M Blok; Ada C M Gigengack-Baars; Ellen M Mascini; Chris van der Werken; Jan Verhoef; Annet Troelstra Journal: Infect Control Hosp Epidemiol Date: 2005-07 Impact factor: 3.254
Authors: Hannah R Day; Eli N Perencevich; Anthony D Harris; Ann L Gruber-Baldini; Seth S Himelhoch; Clayton H Brown; Daniel J Morgan Journal: Infect Control Hosp Epidemiol Date: 2013-01-23 Impact factor: 3.254
Authors: Anthony D Harris; Lisa Pineles; Beverly Belton; J Kristie Johnson; Michelle Shardell; Mark Loeb; Robin Newhouse; Louise Dembry; Barbara Braun; Eli N Perencevich; Kendall K Hall; Daniel J Morgan; Syed K Shahryar; Connie S Price; Joseph J Gadbaw; Marci Drees; Daniel H Kett; L Silvia Muñoz-Price; Jesse T Jacob; Loreen A Herwaldt; Carol A Sulis; Deborah S Yokoe; Lisa Maragakis; Matthew E Lissauer; Marcus J Zervos; David K Warren; Robin L Carver; Deverick J Anderson; David P Calfee; Jason E Bowling; Nasia Safdar Journal: JAMA Date: 2013-10-16 Impact factor: 56.272
Authors: Daniel J Morgan; Lisa Pineles; Michelle Shardell; Margaret M Graham; Shahrzad Mohammadi; Graeme N Forrest; Heather S Reisinger; Marin L Schweizer; Eli N Perencevich Journal: Infect Control Hosp Epidemiol Date: 2012-11-20 Impact factor: 3.254
Authors: Stacey E Baker; Stephen M Brecher; Ernest Robillard; Judith Strymish; Elizabeth Lawler; Kalpana Gupta Journal: Infect Control Hosp Epidemiol Date: 2010-01 Impact factor: 3.254
Authors: Erica S Shenoy; Jiyeon Kim; Eric S Rosenberg; Jessica A Cotter; Hang Lee; Rochelle P Walensky; David C Hooper Journal: Clin Infect Dis Date: 2013-04-09 Impact factor: 9.079
Authors: Erica S Shenoy; Hang Lee; Erin E Ryan; Taige Hou; Rochelle P Walensky; Winston Ware; David C Hooper Journal: Med Decis Making Date: 2017-06-29 Impact factor: 2.583
Authors: Erica S Shenoy; Hang Lee; Taige Hou; Winston Ware; Erin E Ryan; David C Hooper; Rochelle P Walensky Journal: Infect Control Hosp Epidemiol Date: 2016-03-29 Impact factor: 3.254